Earnings Feed
Start Free
Petros Pharmaceuticals, Inc.·4

Jan 3, 6:13 AM ET

SHULMAN JOHN D 4

4 · Petros Pharmaceuticals, Inc. · Filed Jan 3, 2022

Insider Transaction Report

Form 4
Period: 2021-12-22
Petros Pharmaceuticals, Inc.PTPI
SHULMAN JOHN D
Director10% Owner
Transactions
  • Purchase

    Common Stock, par value $0.0001 per share

    2021-12-22$3.43/sh+145,773$500,001→ 5,703,544 total(indirect: See Footnote)
  • Purchase

    Warrant

    2021-12-22+109,329→ 109,329 total(indirect: See Footnote)
    Exercise: $3.50From: 2021-12-27Exp: 2026-12-28→ Common Stock (109,329 underlying)
Footnotes (1)
  • [F1]See Note (1) in Exhibit 99.1.

Documents

3 files